Mankind Pharma
₹2,185.7
-51.05 (-2.28%)
13 May, 2024 13:28 BSE: 543904
NSE: MANKINDISIN: INE634S01028
Start SIP in Mankind Pharma
Start SIPMankind Pharma Performance
Day Range
- Low 2,184
- High 2,244
52 Week Range
- Low 1,242
- High 2,490
- Open Price2,241
- Previous Close2,237
- Volume192046
Mankind Pharma Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 2,359 | 2,453 | 2,300 | 1,872 |
Operating Expenses Qtr Cr | 1,755 | 1,818 | 1,761 | 1,491 |
Operating Profit Qtr Cr | 603 | 635 | 539 | 381 |
Depreciation Qtr Cr | 90 | 77 | 69 | 67 |
Interest Qtr Cr | 4 | 4 | 2 | 1 |
Tax Qtr Cr | 89 | 139 | 117 | 74 |
Net Profit Qtr Cr | 487 | 473 | 409 | 281 |
Mankind Pharma Technicals
EMA & SMA
Current Price
₹2,185.7
-51.05 (-2.28%)
- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- ₹2,288.21
- 50 Day
- ₹2,255.29
- 100 Day
- ₹2,166.76
- 200 Day
- ₹1,994.08
- 20 Day
- ₹2,317.74
- 50 Day
- ₹2,247.73
- 100 Day
- ₹2,169.47
- 200 Day
- ₹1,994.73
Mankind Pharma Resistance and Support
PIVOT
₹2,215.97
Resistance | |
---|---|
First Resistance | 2,275.78 |
Second Resistance | 2,314.82 |
Third Resistance | 2,374.63 |
RSI | 44.17 |
MFI | 35.94 |
MACD Single Line | 11.20 |
MACD | -13.94 |
Support | |
---|---|
First Resistance | 2,176.93 |
Second Resistance | 2,117.12 |
Third Resistance | 2,078.08 |
Mankind Pharma Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 260,690 | 11,569,422 | 44.38 |
Week | 420,924 | 27,881,979 | 66.24 |
1 Month | 390,660 | 25,263,992 | 64.67 |
6 Month | 984,417 | 69,302,990 | 70.4 |
Mankind Pharma Result Highlights
Mankind Pharma Synopsis
NSE-Medical-Products
Mankind Pharma is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 8127.15 Cr. and Equity Capital is Rs. 40.06 Cr. for the Year ended 31/03/2023. Mankind Pharma Ltd. is a Public Limited Listed company incorporated on 03/07/1991 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is U74899DL1991PLC044843 and registration number is 044843.Market Cap | 87,781 |
Sales | 8,984 |
Shares in Float | 10.01 |
No of funds | 253 |
Yield |
Book Value | 11.51 |
U/D Vol ratio | 3.3 |
LTDebt / Equity | |
Alpha | 0.17 |
Beta | 0.48 |
Mankind Pharma
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | 74.88% | 76.5% | 76.5% | 76.5% |
Mutual Funds | 8.57% | 7.55% | 3.9% | 3.92% |
Insurance Companies | 2.17% | 1.94% | 0.5% | 0.55% |
Foreign Portfolio Investors | 9.87% | 6.74% | 4.18% | 4.18% |
Financial Institutions/ Banks | ||||
Individual Investors | 1.22% | 1.14% | 1.11% | 1.02% |
Others | 3.29% | 6.13% | 13.81% | 13.83% |
Mankind Pharma Management
Name | Designation |
---|---|
Mr. Ramesh Juneja | Chairman & Wholetime Director |
Mr. Rajeev Juneja | Vice Chairman & Mng.Director |
Ms. Sheetal Arora | WholeTime Director & CEO |
Mr. Satish Kumar Sharma | Whole Time Director |
Mr. Vivek Kalra | Independent Director |
Mr. Tilokchand Punamchand Ostwal | Independent Director |
Mr. Surendra Lunia | Independent Director |
Mr. Bharat Anand | Independent Director |
Mr. Vijaya Sampath | Independent Director |
Mankind Pharma Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Mankind Pharma Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-05-15 | Audited Results & Others | |
2024-01-31 | Quarterly Results | |
2023-10-31 | Quarterly Results | |
2023-08-02 | Quarterly Results | |
2023-05-30 | Audited Results |
Mankind Pharma FAQs
What is Share Price of Mankind Pharma ?
Mankind Pharma share price is ₹2,185 As on 13 May, 2024 | 13:14
What is the Market Cap of Mankind Pharma ?
The Market Cap of Mankind Pharma is ₹87556.6 Cr As on 13 May, 2024 | 13:14
What is the P/E ratio of Mankind Pharma ?
The P/E ratio of Mankind Pharma is 50.5 As on 13 May, 2024 | 13:14
What is the PB ratio of Mankind Pharma ?
The PB ratio of Mankind Pharma is 11.5 As on 13 May, 2024 | 13:14